Raymond James & Associates Omnicell, Inc Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	SELL	$26.15 - $37.33 $812,742 - $1.16 Million	-31,080 Reduced 32.75%	63,827 $1.87 Million
Q4 2023 Jan 16, 2024	BUY	$29.24 - $45.81 $95,146 - $149,065	3,254 Added 3.55%	94,907 $3.57 Million
Q3 2023 Oct 24, 2023	SELL	$44.6 - $73.38 $2.1 Million - $3.45 Million	-47,009 Reduced 33.9%	91,653 $4.13 Million
Q2 2023 Jul 25, 2023	BUY	$57.88 - $75.94 $299,239 - $392,609	5,170 Added 3.87%	138,662 $10.2 Million
Q1 2023 Apr 14, 2023	SELL	$51.51 - $60.43 $236,894 - $277,917	-4,599 Reduced 3.33%	133,492 $7.83 Million
Q4 2022 Feb 08, 2023	SELL	$46.24 - $90.03 $664,653 - $1.29 Million	-14,374 Reduced 9.43%	138,091 $6.96 Million
Q3 2022 Oct 25, 2022	BUY	$84.23 - $117.38 $1.83 Million - $2.55 Million	21,706 Added 16.6%	152,465 $13.3 Million
Q2 2022 Aug 12, 2022	BUY	$105.64 - $129.11 $198,814 - $242,985	1,882 Added 1.46%	130,759 $14.9 Million
Q1 2022 May 11, 2022	BUY	$120.68 - $180.51 $1.27 Million - $1.89 Million	10,487 Added 8.86%	128,877 $16.7 Million
Q4 2021 Feb 08, 2022	BUY	$153.26 - $183.62 $377,479 - $452,256	2,463 Added 2.12%	118,390 $21.4 Million
Q3 2021 Nov 02, 2021	BUY	$141.84 - $160.88 $2.54 Million - $2.88 Million	17,899 Added 18.26%	115,927 $17.2 Million
Q2 2021 Aug 11, 2021	BUY	$129.91 - $151.45 $174,339 - $203,245	1,342 Added 1.39%	98,028 $14.8 Million
Q1 2021 May 14, 2021	BUY	$117.78 - $143.9 $1.02 Million - $1.25 Million	8,660 Added 9.84%	96,686 $12.6 Million
Q4 2020 Feb 12, 2021	BUY	$73.85 - $120.02 $182,483 - $296,569	2,471 Added 2.89%	88,026 $10.6 Million
Q3 2020 Nov 04, 2020	BUY	$63.15 - $77.12 $1.35 Million - $1.65 Million	21,376 Added 33.31%	85,555 $6.39 Million
Q2 2020 Jul 28, 2020	BUY	$59.36 - $74.43 $3.09 Million - $3.88 Million	52,092 Added 430.98%	64,179 $4.53 Million
Q1 2020 Apr 21, 2020	BUY	$55.41 - $90.19 $82,339 - $134,022	1,486 Added 14.02%	12,087 $793,000
Q4 2019 Feb 12, 2020	BUY	$70.15 - $83.11 $58,855 - $69,729	839 Added 8.59%	10,601 $866,000
Q3 2019 Nov 07, 2019	SELL	$68.36 - $88.34 $160,919 - $207,952	-2,354 Reduced 19.43%	9,762 $705,000
Q2 2019 Aug 06, 2019	SELL	$71.38 - $92.21 $174,809 - $225,822	-2,449 Reduced 16.81%	12,116 $1.04 Million
Q1 2019 May 06, 2019	BUY	$58.88 - $86.19 $120,232 - $175,999	2,042 Added 16.31%	14,565 $1.18 Million
Q4 2018 Feb 11, 2019	BUY	$56.97 - $77.23 $81,808 - $110,902	1,436 Added 12.95%	12,523 $767,000
Q3 2018 Nov 14, 2018	SELL	$52.65 - $71.9 $12,214 - $16,680	-232 Reduced 2.05%	11,087 $797,000
Q2 2018 Aug 14, 2018	BUY	$42.2 - $53.05 $1,012 - $1,273	24 Added 0.21%	11,319 $594,000
Q1 2018 May 14, 2018	SELL	$40.1 - $52.45 $12,070 - $15,787	-301 Reduced 2.6%	11,295 $490,000
Q4 2017 Feb 14, 2018	SELL	$45.3 - $54.5 $1.44 Million - $1.73 Million	-31,751 Reduced 73.25%	11,596 $562,000
Q3 2017 Nov 13, 2017	SELL	$48.1 - $52.15 $2,212 - $2,398	-46 Reduced 0.11%	43,347 $2.21 Million
Q2 2017 Aug 14, 2017	BUY	N/A	43,393	43,393 $1.87 Million

Others Institutions Holding OMCL

# of Institutions

274

Shares Held

44.3M

Call Options Held

224K

Put Options Held

35.7K

Black Rock Inc. New York, NY

8.18M
Shares

$346 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.53M
Shares

$234 Million
0.0% of portfolio
State Street Corp Boston, MA

2.27M
Shares

$95.9 Million
0.0% of portfolio
Champlain Investment Partners, LLC Burlington, VT

1.55M
Shares

$65.4 Million
0.43% of portfolio
Dimensional Fund Advisors LP Austin, TX

1.25M
Shares

$52.8 Million
0.01% of portfolio

View Full List

About OMNICELL, Inc

Ticker OMCL
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 44,288,800
Market Cap $1.87B
Description
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...

More about OMCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account